Neudle.com: anticholinesterase

Differential
(Click to cross reference)

acetylcholine

acetylcholine receptor

acetylcholine receptor antibody

acetylcholinesterase

activities of daily living

advance directives

advances in neurology

adverse drug reaction

age associated memory impairment

Alzheimer's disease, behavioral symptoms

Alzheimer's disease, diagnosis of

Alzheimer's disease, driving with

Alzheimer's disease, early symptoms

Alzheimer's disease, familial

Alzheimer's disease, pathogenesis

Alzheimer's disease, preclinical

Alzheimer's disease, risk factors in

Alzheimer's disease, treating associated medical problems in

Alzheimer's disease, treatment of

antibiotics, neurologic complications with

anticholinergic drugs

anticholinergic drugs, side effects of

anticholinesterase

anticonvulsants

anticonvulsants, untoward effects of

antidepressant

antioxidant

antistriational muscle antibody

apraxia, constructional

arthralgia

arthrogryposis multiplex

autonomic dysfunction

beta adrenergic blocker

caloric testing, unconscious patient

CAT scan, emission, abnormal

cerebellar atrophy, primary

cerebrospinal fluid, elevated protein of

chronic fatigue syndrome

clonazepam

clozapine

clubfoot as related to neurologic disease

congenital myasthenic syndromes

consanguinity

contrast agents, neurotoxicity of

controversies in neurology

dementia, cerebrovascular disease causing

dementia, diagnostic classification

dementia, diagnostic evaluation of

dementia, prevention of

dementia, treatment of

dementia, unknown etiology

deprenyl

depression

developmental retardation

diarrhea

differential diagnosis

drug abuse, neurologic complications of

drug induced neurologic disorders

dystonia, drug induced

dystonia, face

dystonic reaction, acute

eating disorder

echolalia

efficacy

electroconvulsive therapy

electromyogram

electromyogram, decremental response

emergencies, neurologic

enzyme inhibition

ephedrine

ergonovine

evidence-based research

executive dysfunction

facial hallucinations

gammaglobulin therapy, intravenous

gene

gene mutation

genetic neurologic disorders

Gilles de la Tourette syndrome

heralding manifestation

iatrogenic neurologic disorders

immunologic disease

immunosuppressive agents

inappropriate behavior

intestinal pseudoobstruction

irritability

lacrimation

lecithin

level of consciousness, decreased

Lewy body disease, diffuse

lid abnormalities

lid closure, weakness of

liver function enzymes

malabsorption

malformation, CNS, congenital

memory, defect of recent

memory, disorder, treatment of

memory, impairment of

memory, impairment of, subjective

mestinon

metrifonate

microcephaly

mild cognitive impairment

Mini Mental Status Examination

movement disorder, drug induced

muscle weakness, proximal

myasthenia gravis

myasthenia gravis, anticholinesterase malabsorption in

myasthenia gravis, anticholinesterase serum levels in

myasthenia gravis, classification

myasthenia gravis, diagnosis

myasthenia gravis, differential diagnosis

myasthenia gravis, drug induced

myasthenia gravis, etiology of

myasthenia gravis, infantile and juvenile

myasthenia gravis, misdiagnosis of

myasthenia gravis, neuromuscular junction in

myasthenia gravis, ocular

myasthenia gravis, presenting manifestations

myasthenia gravis, prognosis of

myasthenia gravis, receptor site in

myasthenia gravis, remission of

myasthenia gravis, seronegative

myasthenia gravis, thymectomy in

myasthenia gravis, treatment of

myasthenia gravis, unmasked

neuroleptic malignant syndrome

neuroleptic, atypical

neurologic consultation

neurologic disease

neurologic disease, diagnoses of

neurologic signs

neurologic symptoms

neuromuscular blockade

neuromuscular disease, electrodiagnosis of

neuromuscular junction

neuromuscular junction, abnormality of

nonsteroidal anti-inflammatory drug

nursing home

nystagmus

occupational neurologic disorders

ocular motility, disorders of

oculocephalic reflex

olanzapine

old age, neurology of

opened mouth

ophthalmoplegia

ophthalmoplegia, total

Parkinson disease, dementia with

Parkinson disease, nonmotor problems of

Parkinsonism syndrome

patient information and support

penicillamine

penicillin

personality change

phencyclidine poisoning

Pittsburgh Compound B

plasmapheresis

poison, neurologic problems with

poison, organophosphate

polyneuropathy

postural abnormality

practice guidelines

pregnancy, neurologic complications in

premarin

prevention of neurologic disorders

prognosis

propranolol

prosopometamorphopsia

prostigmine

pseudointernuclear ophthalmoplegia

psychiatric disorder

psychiatric problems in neurologic disorders

psychological testing

psychomotor retardation

pupil, dilated, bilateral

repetitive nerve stimulation

repetitive questioning

reserpine and reserpine like drugs

respiratory failure

respiratory paralysis, pharmacologic

risk-benefit assessment

risperidone

rivastigmine

rummaging

saccadic eye movements

saccadic eye movements, abnormal

safety

salivation, excessive

Sarin

seizure

seizure, drug-induced

selective serotonin reuptake inhibitors

senile plaques

seronegative

serum alanine aminotransferase

shadowing

single photon emission computed tomography

single-fiber electromyography

sleep

sleep pathology and physiology

snake bite

Soman

spinocerebellar ataxia type 1

spinocerebellar degeneration

stereotyped behavior

steroid

steroid therapy, CNS treatment and complications with

sumatriptan

sympathomimetic drugs

tardive dyskinesia, treatment of

tensilon

tensilon test, false negative

tensilon test, false positive

tensilon test, paradoxical

tetrabenazine

tetrahydroaminoacridine

thymectomy

thymoma

thymus and neuromuscular function

toxins, nervous system

treatment of neurologic disorder

treatment, non-pharmacologic

upgaze, paralysis of

vaccination, neurologic complications with

visuospatial disturbance

vitamin E

vitamin K

voice, abnormality of

weakness, generalized

Showing articles 100 to 131 of 131 << Previous

Management of Injuries Due to Chemical Weapons
BMJ 302:129-130, Murray,V.S.G.&Volans,G.N., 1991

Tacrine in Alzheimer's Disease
Lancet 337:989-992, Eagger,S.A.,et al, 1991

Pyridostigmine Used as a Nerve Agent Pretreatment Under Wartime Conditions
JAMA 266:693-695, Keeler,J.R.,et al, 1991

Tacrine (tetrahydroaminoacridine; THA) and Lecithin in Senile Dememtia of the Alzheimer Type:A Multicentre Trial
BMJ 300:495-499, Chatellier,G.,et al, 1990

Tetrahydroaminoacridine-Lecithin Combination Treatment in Patients with Intermediate-Stage Alzheimer's Disease
NEJM 322:1272-1276, Gauthier,S.,et al, 1990

Tetrahydroaminoacridine (THA) in Alzheimer's Disease, Not Ready for Routine Use
BMJ 298:845-846, Graham,T.R.&Lewis,C.T., 1989

Long-Term Administration of Oral Physostigmine in Alzheimer's Disease
Neurol 38:1837-1841, Stern,Y.,et al, 1988

Effects of Oral Physostigmine in Alzheimer's Disease
Ann Neurol 22:306-310, Stern,Y.,et al, 1987

Physostigmine Improves ECT-Induced Memory Disturbances
Neurol 37:871-875, Levin,Y.,et al, 1987

Oral Tetrahydroaminoacridine in Long-Term Treatment of Senile Dementia, Alzheimer Type
NEJM 315:1241-1245, Summers,W.K.,et al, 1986

Positive Response to Edrophonium in Patients with Neurotoxic Envenoming by Cobras (NAJA NAJA PHILIPPINENIS)
NEJM 315:1444-1448, Watt,G.,et al, 1986

Drug-Induced Seizures:A 10-Year Experience
Neurol 34:1582-1586, Messing,R.O.,et al, 1984

Memory Enhancement with Oral Physostigmine in Alzheimer's Disease
NEJM 308:720-721, Thal,L.J.,et al, 1983

Oral Physostigmine & Lecithin Improve Memory in Alzheimer Disease
Ann Neurol 13:491-496, Thal,L.J.,et al, 1983

Memory Decline in the Aged:Treatment with Lecithin & Physostigmine
Neurol 32:944-950, Drachman,D.A.,et al, 1982

Double-blind, Triple-crossover Trial of Low Doses of Oral Physostigmine in Inherited Ataxias
Neurol 31:288-292, Kark,R.A.P.,et al, 1981

Plasma Pyridostigmine Levels in Myasthenia Gravis
Neurol 31:145-150, White,M.C.,et al, 1981

Amitriptyline-induced Ophthalmoplegia
Neurol 31:1188-1190, Spector,R.H.,et al, 1981

Physostigmine In Gilles De La Tourettes Syndrome
NEJM 302:298, Stahl,S.M.,et al, 1980

Memory & Cognitive Function in the Elderly, A Preliminary Trial of Physostigmine
Arch Neurol 37:674-675, Drachman,D.A.,et al, 1980

Controversies About the Treatment of Myasthenia Gravis
JNNP 43:644-659, Rowland,L.P., 1980

Anticholinergic Toxicity
NEJM 300:1278, Caine,E.D., 1979

Physostigmine in Reye Syndrome
Ann Neurol 5:105, Pettegrew,J.W.,et al, 1979

Effects of Physostigmine & Lecithin on Memory in Alzheimer Disease
Ann Neurol 6:219-221, Peters,B.H.,et al, 1979

Enhancement Of Memory By Physostigmine
NEJM 301:946, Davis,K.L.,et al, 1979

Meige Disease:Striatal Dopaminergic Preponderance
Neurol 29:1126-1130, Tolosa,E.S.,et al, 1979

Amantadine Intoxication Reversed by Physostigmine
NEJM 298:516, Casey,D.E., 1978

Physostigmine in Familial Ataxias
Neurol 27:70, Kark,R.A.,et al, 1977

Drug Therapy of Tardive Dyskinesia
NEJM 296:257, Kobayashi,R.M., 1977

Pheniramine Aminosalicylate Overdosage:Reversal of Delirium & Choreiform Movements with Tacrine Treatment
Arch Neurol 34:313, Mendelson,G.,et al, 1977

Malabsorption of Pyridostigmine in Patients with Masthenia Gravis
Neurol 27:299, Cohan,S.L.,et al, 1977

Total Gaze Paresis in Amitriptyline Overdose
Neurol 27:695, Miadinich,E.K.,et al, 1977

Showing articles 100 to 131 of 131 << Previous